Illuminating tissue formation

Image of tumour boundary taken using fluorescence microscopy. The new marker molecule shows the boundary of the tumour in blue; the tumour tissue can be seen above it on the left. Green: collagen, red: cell nuclei.
Credit: ETH Zurich / Matthew Aronoff

Collagen is the most abundant protein in the human body. It makes up a third of protein content and single strands assemble to form stable fibres that give structure to connective tissue such as skin, tendons, cartilage and bones. Researchers at ETH Zurich have now developed a multi-component molecule that interacts with collagen and can be used to illuminate new tissue growth in the body.

Our bodies start producing more collagen as wounds heal – or as tumours grow. During this process, the fibrous collagen molecules cross-link to create stable fibres. This requires LOX enzymes, which oxidise certain sites in the collagen molecules. Subsequently, the chemically altered sites on different collagen strands react with each other, causing the strands to fuse together.

Sensor combined with functional peptide

Led by Professor Helma Wennemers, a professor at the Laboratory of Organic Chemistry at ETH Zurich, the team of researchers developed a sensor molecule with inducible fluorescence. The molecule itself isn’t fluorescent, but after reacting with the LOX enzyme, it begins to light up. In this way, the sensor molecule acts as a marker for LOX activity. Next, the scientists combined this molecule with a short fibrous peptide similar to collagen. They conjugated this peptide with a what is known as a reactive group that reacts with collagen only if the latter has been oxidised.

In collaboration with researchers from the group led by Sabine Werner, Professor of Cell Biology, the scientists conducted experiments with mice whose skin had been injected with the multi-component molecule. They also performed in vitro experiments with tissue sections. Their investigations revealed that the molecule anchors itself to collagen fibres where new tissue is being formed. And it lights up when new tissue starts growing and the LOX enzyme is being formed. “Thanks to its modular design with three components – the sensor, the peptide and the reactive group – our system is exceptionally specific and precise,” says Matthew Aronoff, senior scientist in Wennemers’ group and lead author of the study.

Applications in oncology and wound healing

Because new tissue forms primarily at the edges of tumours as they grow, one application for the new molecule is in biopsy examinations to show the boundaries of a tumour. “One of our visions is that surgeons will one day use this molecule in an operating theatre when removing a tumour,” Wennemers says. The molecule would show surgeons the boundary of the tumour and help them to remove it entirely.

Other potential applications for the new marker molecule are in the field of wound healing, for example to investigate tissue formation in general or healing disorders in patients suffering from diabetes or other diseases. Such questions are also addressed within the framework of the interdisciplinary skin research project Skintegrity, in which ETH Zurich is involved.

Having applied for a patent for their system, the scientists are currently exploring various options for bringing it to market and developing it for a wider range of applications.

Last year, the researchers were awarded ETH Zurich’s Spark Award for this work, which has now been published in a scientific journal for the first time. Further information is provided in this video:

https://youtu.be/fKmNR7XpWtk (Video: ETH Zurich)

Reference

Aronoff MR, Hiebert P, Hentzen NB, Werner S, Wennemers H: Imaging and targeting LOX-mediated tissue remodeling with a reactive collagen peptide. Nature Chemical Biology, 12 July 2021, doi: 10.1038/s41589-021-00830-6 [https://doi.org/10.1038/s41589-021-00830-6]

Journal: Nature Chemical Biology
DOI: 10.1038/s41589-​021-00830-6

Media Contact

Media Relations
mediarelations@hk.ethz.ch
Office: +41 44 632 41 41

Expert Contact

Prof. Dr. Helma Wennemers
helma.wennemers@org.chem.ethz.ch
Office: +41 44 633 37 77

www.ethz.ch

Media Contact

Media Relations
ETH Zurich

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

A microscope image of lung cancer cells (purple) containing the activated form of a metabolic enzyme called GUK1 (brown) that supports cancer growth. Image Credit: Image: Haigis lab

New Insights Uncover Lung Cancer’s Defensive Weaknesses

Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth  At a glance: Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively…

The study’s lead author, Sara Gonzalez, and co-authors Hadley Kerr and Maggie Aydlett, record phenotyping data at WHOI’s Environmental Systems. Image Credit: ©Woods Hole Oceanographic

Heat-Resistant Kelp Strain Discovered by Woods Hole Scientists

A new strain of kelp can help support sustainable farming  Like most aquatic vegetation, kelp is being negatively impacted by climate change. Warming ocean temperatures have led to shorter growing…

A codon, a sequence of three nucleotides in DNA and RNA that codes for a specific amino acid, acts like an “instruction manual” for protein synthesis, telling the cell which of the 20 natural amino acids to add to a growing protein chain — or, in the case of the three “stop” codons (known as TAG, TGA, and TAA), signaling the termination of protein synthesis. Yale scientists recoded a cell to have a single, non-degenerative TAA codon. The newly “free” TGA and TAG codons have been reassigned to encode nonstandard amino acids into synthetic proteins that possess new chemistries with innumerable applications. Image Credit: Yale University / Michael S. Helfenbein

Yale Scientists Redefine Genome for Programmable Proteins

Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism (GRO) with one stop codon — using a cellular platform…